Literature DB >> 26143056

Enterobacter Strains Might Promote Colon Cancer.

Dilşad Yurdakul1, Ayten Yazgan-Karataş, Fikrettin Şahin.   

Abstract

Many studies have been performed to determine the interaction between bacterial species and cancer. However, there has been no attempts to demonstrate a possible relationship between Enterobacter spp. and colon cancer so far. Therefore, in the present study, it is aimed to investigate the effects of Enterobacter strains on colon cancer. Bacterial proteins were isolated from 11 Enterobacter spp., one Morganella morganii, and one Escherichia coli strains, and applied onto NCM460 (Incell) and CRL1790 (ATCC) cell lines. Cell viability and proliferation were determined in MTS assay. Flow Cytometry was used to detect CD24 level and apoptosis. Real-Time PCR studies were performed to determine NFKB and Bcl2 expression. Graphpad Software was used for statistical analysis. The results showed that proteins, isolated from the Enterobacter spp., have significantly increased cell viability and proliferation, while decreasing the apoptosis of the cell lines tested. The data in the present study indicated that Enterobacter strains might promote colon cancer. Moreover, Enterobacter spp. could be a clinically important factor for colon cancer initiation and progression. Studies can be extended on animal models in order to develop new strategies for treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26143056     DOI: 10.1007/s00284-015-0867-x

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  33 in total

1.  16S ribosomal DNA amplification for phylogenetic study.

Authors:  W G Weisburg; S M Barns; D A Pelletier; D J Lane
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

2.  Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer.

Authors:  A L Laurila; T Anttila; E Läärä; A Bloigu; J Virtamo; D Albanes; M Leinonen; P Saikku
Journal:  Int J Cancer       Date:  1997-02-20       Impact factor: 7.396

Review 3.  NF-kappaB signaling pathway, inflammation and colorectal cancer.

Authors:  Soly Wang; Zhanjie Liu; Lunshan Wang; Xiaoren Zhang
Journal:  Cell Mol Immunol       Date:  2009-10       Impact factor: 11.530

Review 4.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

5.  Inhibition of apoptosis as a mechanism of tumor promotion.

Authors:  S C Wright; J Zhong; J W Larrick
Journal:  FASEB J       Date:  1994-06       Impact factor: 5.191

Review 6.  Inflammation and colon cancer.

Authors:  Janos Terzić; Sergei Grivennikov; Eliad Karin; Michael Karin
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

7.  Bacterial infection promotes colon tumorigenesis in Apc(Min/+) mice.

Authors:  J V Newman; T Kosaka; B J Sheppard; J G Fox; D B Schauer
Journal:  J Infect Dis       Date:  2001-06-18       Impact factor: 5.226

Review 8.  Colon cancer: genomics and apoptotic events.

Authors:  Charleen Rupnarain; Zodwa Dlamini; Sarala Naicker; Kanti Bhoola
Journal:  Biol Chem       Date:  2004-06       Impact factor: 3.915

Review 9.  Colon cancer and apoptosis.

Authors:  Sergio Huerta; Emily J Goulet; Edward H Livingston
Journal:  Am J Surg       Date:  2006-04       Impact factor: 2.565

10.  Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis).

Authors:  Jordane Biarc; Isabelle S Nguyen; Annelise Pini; Francine Gossé; Sophie Richert; Danielle Thiersé; Alain Van Dorsselaer; Emmanuelle Leize-Wagner; Francis Raul; Jean-Paul Klein; Marie Schöller-Guinard
Journal:  Carcinogenesis       Date:  2004-01-23       Impact factor: 4.944

View more
  10 in total

1.  The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs).

Authors:  Amr Mohamed; Sylvia L Asa; Thomas McCormick; Hilmi Al-Shakhshir; Arvind Dasari; Retuerto Mauricio; Iman Salem; Lee M Ocuin; David Bajor; Richard T Lee; J Eva Selfridge; Arash Kardan; Zhenghong Lee; Norbert Avril; Shelby Kopp; Jordan M Winter; Jeffrey M Hardacre; John B Ammori; Mahmoud A Ghannoum
Journal:  Curr Issues Mol Biol       Date:  2022-04-30       Impact factor: 2.976

Review 2.  Potential influence of the microbiome environment in patients with biliary tract cancer and implications for therapy.

Authors:  Roseanna C Wheatley; Elaine Kilgour; Timothy Jacobs; Angela Lamarca; Richard A Hubner; Juan W Valle; Mairéad G McNamara
Journal:  Br J Cancer       Date:  2021-10-18       Impact factor: 9.075

3.  Alterations in co-abundant bacteriome in colorectal cancer and its persistence after surgery: a pilot study.

Authors:  Chin-Wen Png; Yong-Kang Chua; Jia-Hao Law; Yongliang Zhang; Ker-Kan Tan
Journal:  Sci Rep       Date:  2022-06-14       Impact factor: 4.996

Review 4.  The Microbiome in Pancreatic Cancer-Implications for Diagnosis and Precision Bacteriophage Therapy for This Low Survival Disease.

Authors:  Mwila Kabwe; Stuart Dashper; Joseph Tucci
Journal:  Front Cell Infect Microbiol       Date:  2022-05-19       Impact factor: 6.073

5.  Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner.

Authors:  Palak J Trivedi; Joseph Tickle; Mette Nåmdal Vesterhus; Peter J Eddowes; Tony Bruns; Jani Vainio; Richard Parker; David Smith; Evaggelia Liaskou; Liv Wenche Thorbjørnsen; Gideon M Hirschfield; Kaisa Auvinen; Stefan G Hubscher; Marko Salmi; David H Adams; Chris J Weston
Journal:  Gut       Date:  2017-04-20       Impact factor: 23.059

6.  Bladder cancer-related microbiota: examining differences in urine and tissue samples.

Authors:  Bassel Mansour; Ádám Monyók; Nóra Makra; Márió Gajdács; István Vadnay; Balázs Ligeti; János Juhász; Dóra Szabó; Eszter Ostorházi
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

7.  Composition of the mucosa-associated microbiota along the entire gastrointestinal tract of human individuals.

Authors:  Fer Vuik; J Dicksved; S Y Lam; G M Fuhler; Ljw van der Laan; A van de Winkel; S R Konstantinov; McW Spaander; M P Peppelenbosch; L Engstrand; E J Kuipers
Journal:  United European Gastroenterol J       Date:  2019-05-17       Impact factor: 4.623

8.  Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma.

Authors:  Ben Lin; Meng Wang; Renyuan Gao; Zhao Ye; Yifei Yu; Wenqiang He; Nidan Qiao; Zengyi Ma; Chenxing Ji; Chengzhang Shi; Xiang Zhou; Yi Wang; Fangfang Zeng; Li Zhang; Wei Gong; Zhan Cao; Peng Zhou; Vladimir Melnikov; Hongying Ye; Yiming Li; Zhaoyun Zhang; Min He; Huanlong Qin; Yichao Zhang
Journal:  Microbiol Spectr       Date:  2022-01-12

9.  Dysbiosis of the Gut Microbiome Is Associated With Histopathology of Lung Cancer.

Authors:  Xiong Qin; Ling Bi; Wenxiao Yang; Yiyun He; Yifeng Gu; Yong Yang; Yabin Gong; Yichao Wang; Xiaoxia Yan; Ling Xu; Haibo Xiao; Lijing Jiao
Journal:  Front Microbiol       Date:  2022-06-14       Impact factor: 6.064

10.  Two Newly Isolated Enterobacter-Specific Bacteriophages: Biological Properties and Stability Studies.

Authors:  Martyna Cieślik; Marek Harhala; Filip Orwat; Krystyna Dąbrowska; Andrzej Górski; Ewa Jończyk-Matysiak
Journal:  Viruses       Date:  2022-07-12       Impact factor: 5.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.